SCHEMBL13006162

SCHEMBL13006162

COc1ccc(COc2c(C=O)cccc2-c2ccc(C(=O)N(C)C)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 3/20 0.43
NPC1 O15118 3/20 0.43
RAB9A P51151 2/20 0.43
POLB P06746 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
LPAR1 Q92633 1/20 0.41
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SLC2A1 P11166 2/20 0.39
SMPD1 P17405 1/20 0.39
FFAR1 O14842 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
PLA2G4B P0C869 1/20 0.39
TBXAS1 P24557 1/20 0.39
FYN P06241 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13060854 0.85 NPC1 (0.46) NPC1RAB9APOLBSMN1; SMN2TDP1
SCHEMBL13006174 0.83 ERN1 (0.53) ERN1SMN1; SMN2ALDH1A1MAPTMEN1
SCHEMBL13005468 0.82 NPC1 (0.43) NPC1RAB9APOLBSMN1; SMN2TDP1
SCHEMBL13006165 0.82 CYP1A2 (0.45) NPC1RAB9APOLBSMN1; SMN2TDP1
SCHEMBL13006167 0.78 NPC1 (0.39) NPC1RAB9APOLBSMN1; SMN2TDP1
SCHEMBL2108698 0.76 SLC2A1 (0.53) NPC1RAB9APOLBSMN1; SMN2LPAR1
SCHEMBL31482105 0.74 KMT2A (0.51) SMN1; SMN2TDP1ALDH1A1MAPTHTT
SCHEMBL26163562 0.73 TDP1 (0.52) ERN1NPC1RAB9APOLBSMN1; SMN2
SCHEMBL696160 0.73 NPC1 (0.55) NPC1RAB9ASMN1; SMN2TDP1ALDH1A1
SCHEMBL13006159 0.72 NPC1 (0.53) NPC1RAB9APOLBSMN1; SMN2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed